![Gregory Moss](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Moss
Compliance Officer chez
EVOMMUNE, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Gregory S.
Moss is currently Director at Vitls, Inc., Independent Director at Anteris Technologies Global Corp.
starting in 2025, Member of the New York State Bar Association, Member of the New South Wales Bar Association, and Secretary, Chief Compliance & Business Officer at Evommune, Inc. since 2022.
Formerly, Mr. Moss was Director at MeiraGTx Holdings Plc from 2018 to 2019, Secretary, Chief Compliance Officer & EVP at Kadmon Holdings, Inc. from 2012 to 2022, and General Counsel & Compliance Officer at MeiraGTx Ltd. from 2015 to 2016.
Education includes undergraduate and graduate degrees from Macquarie University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EVOMMUNE, INC. 0,18 % | 28/05/2026 | 64 010 ( 0,18 % ) | 1 M $ | 31/05/2026 |
0,02 % | 07/06/2026 | 17 580 ( 0,02 % ) | 151 540 $ | 31/05/2026 |
Postes actifs de Gregory Moss
| Sociétés | Poste | Début |
|---|---|---|
| EVOMMUNE, INC. | Compliance Officer | 01/06/2022 |
New York State Bar Association
 New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Corporate Officer/Principal | - |
New South Wales Bar Association | Corporate Officer/Principal | - |
Vitls, Inc.
 Vitls, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops wearable medical devices for homes and hospitals | Directeur/Membre du Conseil | - |
Anciens postes connus de Gregory Moss
| Sociétés | Poste | Fin |
|---|---|---|
| KADMON HOLDINGS, INC. | Compliance Officer | 01/06/2022 |
| MEIRAGTX HOLDINGS PLC | Directeur/Membre du Conseil | 19/06/2019 |
MeiraGTx Ltd.
 MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology Develops novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders | Compliance Officer | 01/12/2016 |
Formation de Gregory Moss
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Kadmon Holdings, Inc.
 Kadmon Holdings, Inc. BiotechnologyHealth Technology Discovers, develops and delivers transformative therapies for unmet medical needs | Health Technology |
Macquarie University
 Macquarie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Commercial Services |
New South Wales Bar Association | Government |
MeiraGTx Ltd.
MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology Develops novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders | Health Technology |
MeiraGTx Holdings Plc
 MeiraGTx Holdings Plc BiotechnologyHealth Technology Develops and manufactures genetic medicines | Health Technology |
Vitls, Inc.
Vitls, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops wearable medical devices for homes and hospitals | Electronic Technology |
Evommune, Inc.
 Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
